Headline News: Our Data Monitoring Committee applaud SEND recruitment. They find statistical significance in interim results and recommend trial closure to new patients, rapid publication and maintain follow up of all patients for 5 years.
The SEND trial is looking at two commonly used surgical techniques for the treatment of early mouth cancer. After an early analysis of the results, our Data Monitoring Committee have found that there is enough evidence available to determine the best course of treatment for patients and so our flagship clinical trial will no longer be recruiting patients. Over the coming months we will be collecting and analysing the final data. We will be publishing the results in the near future.